Market capitalization | €854.52m |
Enterprise Value | €972.15m |
P/E (TTM) P/E ratio | 7.53 |
EV/FCF (TTM) EV/FCF | 6.73 |
EV/Sales (TTM) EV/Sales | 0.29 |
P/S ratio (TTM) P/S ratio | 0.26 |
P/B ratio (TTM) P/B ratio | 0.60 |
Dividend yield | 3.95% |
Last dividend (FY23) | €1.80 |
As a Free StocksGuide user, you can view scores for all 6,885 stocks worldwide.
6 Analysts have issued a Drägerwerk forecast:
6 Analysts have issued a Drägerwerk forecast:
Sep '24 |
+/-
%
|
||
Revenue | 3,348 3,348 |
0%
0%
|
|
Gross Profit | 1,456 1,456 |
1%
1%
|
|
EBITDA | 293 293 |
3%
3%
|
EBIT (Operating Income) EBIT | 152 152 |
9%
9%
|
Net Profit | 113 113 |
21%
21%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Drägerwerk AG & Co. KGaA engages in the provision of medical and safety technology products. It operates through the following geographical segments: Europe; Americas; and Africa, Asia, and Austria (AAA). The company was founded by Johann Heinrich Draeger in 1889 and is headquartered in Luebeck, Germany.
Head office | Germany |
CEO | Stefan Dräger |
Employees | 16,329 |
Founded | 1889 |
Website | www.draeger.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.